
Featured
High-Dose Vitamin D Fails to Outperform Standard Dosing in Advanced Colorectal Cancer, Landmark SOLARIS Trial Finds
The phase 3 SOLARIS trial, published in JAMA on August 6, 2026, found high-dose vitamin D3 offered no overall survival advantage over standard dosing ...
Read Full Story →
